Trials / Unknown
UnknownNCT05576493
Combined Phacoemulsification and Diode Laser Therapy in Chronic Angle Closure Glaucoma
Combined Phacoemulsification and Different Modes of Diode Laser Therapy in Management of Chronic Angle Closure Glaucoma. A Comparative Study
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 88 (estimated)
- Sponsor
- Cairo University · Academic / Other
- Sex
- All
- Age
- 20 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
comparing different types of cuclophotocoagulation with cataract extraction to cataract extraction and goniocynechiolysis in cases of chronic angle closure glaucoma
Detailed description
Evaluation of the safety of MP-TSCPC , CW-TSCPC and endoscopic cyclophotocoagulation when combined with phacoemulsification in cases with CACG Comparing the efficacy of the combined procedures in control of the IOP and the success rate versus lens extraction combined with synechiolysis
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | phaco+MP-TSCPC | The procedure starts with performing the cyclophotocoagulation using the Micropulse P3 device (IQ 810 Laser Systems; Iridex, Mountain View, CA, USA) at 2500 mW with a duration of 90 seconds in each hemisphere at a 31.3% duty cycle under local anesthesia and then performing phacoemulsification and IOL implantation. |
| PROCEDURE | phaco+TSCPC | The procedure starts with performing the cyclophotocoagulation using the IRIDEX's G probe device (IRIDEX Corp. Mountain View, CA, USA) at 1500 to2000 mW with a duration of 1500 ms applying about 15 shots in one hemisphere only under local anesthesia and then performing phacoemulsification and IOL implantation. |
| PROCEDURE | phaco+endocyclophotocoagulation | phacoemulsification will be done and endocyclophotocoagulation will be done after cataract extraction |
| PROCEDURE | phaco GSL | phacoemulsification will be done and then the angle is visualized by direct goniolens then the synechia are dissected by cohesive viscoelastic. |
Timeline
- Start date
- 2022-08-11
- Primary completion
- 2023-10-01
- Completion
- 2023-12-01
- First posted
- 2022-10-12
- Last updated
- 2023-08-30
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT05576493. Inclusion in this directory is not an endorsement.